tradingkey.logo

Park Ha Biological Technology Co Ltd

PHH
0.366USD
-0.008-2.19%
Cierre 10/23, 16:00ETCotizaciones retrasadas 15 min
10.74MCap. mercado
--P/E TTM

Park Ha Biological Technology Co Ltd

0.366
-0.008-2.19%

Más Datos de Park Ha Biological Technology Co Ltd Compañía

Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market.

Información de Park Ha Biological Technology Co Ltd

Símbolo de cotizaciónPHH
Nombre de la empresaPark Ha Biological Technology Co Ltd
Fecha de salida a bolsaDec 27, 2024
Director ejecutivoMs. Xiaoqiu Zhang
Número de empleados31
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 27
Dirección14F, Building 3
CiudadWUXI
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísChina
Código postal214135
Teléfono864000127562
Sitio Webhttp://ir.parkha.cn/
Símbolo de cotizaciónPHH
Fecha de salida a bolsaDec 27, 2024
Director ejecutivoMs. Xiaoqiu Zhang

Ejecutivos de Park Ha Biological Technology Co Ltd

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Mr. Xiaozhong Yu
Mr. Xiaozhong Yu
Independent Director Nominee
Independent Director Nominee
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--

Desglose de ingresos

FY2024
FY2023
FY2022
FY2021
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
China (Mainland)
2.38M
0.00%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 23 de ago
Actualizado: sáb., 23 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Xiaoqiu Holding Ltd
56.24%
Changxin International Ltd Partnership
7.38%
Citadel Advisors LLC
0.06%
Invesco Capital Management LLC
0.06%
Geode Capital Management, L.L.C.
0.05%
Otro
36.21%
Accionistas
Accionistas
Proporción
Xiaoqiu Holding Ltd
56.24%
Changxin International Ltd Partnership
7.38%
Citadel Advisors LLC
0.06%
Invesco Capital Management LLC
0.06%
Geode Capital Management, L.L.C.
0.05%
Otro
36.21%
Tipos de accionistas
Accionistas
Proporción
Corporation
63.62%
Investment Advisor
0.13%
Research Firm
0.10%
Hedge Fund
0.07%
Investment Advisor/Hedge Fund
0.05%
Otro
36.04%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
15
115.17K
0.34%
+64.73K
2025Q2
9
21.62M
81.98%
-25.58K
2025Q1
8
21.60M
81.90%
-29.47K
2024Q4
6
21.63M
82.55%
+21.63M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Xiaoqiu Holding Ltd
19.05M
56.24%
--
--
Feb 24, 2025
Changxin International Ltd Partnership
2.50M
7.38%
--
--
Feb 24, 2025
Citadel Advisors LLC
21.23K
0.06%
+4.63K
+27.87%
Jun 30, 2025
Invesco Capital Management LLC
20.61K
0.06%
+20.61K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
16.85K
0.05%
+69.00
+0.41%
Jun 30, 2025
State of Wyoming
12.02K
0.04%
+12.02K
--
Jun 30, 2025
BNP Paribas Securities Corp. North America
12.03K
0.04%
+12.03K
--
Jun 30, 2025
Scientech Research LLC
8.35K
0.02%
+8.35K
--
Jun 30, 2025
Morgan Stanley & Co. LLC
7.03K
0.02%
+7.03K
--
Jun 30, 2025
Scotia Capital Inc.
6.00K
0.02%
+6.00K
--
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
Invesco Golden Dragon China ETF
0.01%
Invesco Golden Dragon China ETF
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI